Tradestie Institutional Equity Comparison Engine

ATRC vs AXNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATRC Overall Edge

ATRC Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AtriCure, Inc. (ATRC) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ATRC trades at 122.1x Forward P/E with 2.9% operating margin (+15.0% YoY revenue) versus AXNX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ATRC sits in UNCLASSIFIED (74th %ile IV; Dealer Gamma Walls on Pro) against AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ATRC
ATRC 122.1x vs AXNX N/M Fwd P/E
Growth & Margin Winner ATRC
Op Margin 2.9% vs N/A ยท YoY +15.0% vs N/A
Momentum & Technical Winner ATRC
1Y +62.0% vs +16.9% ยท 52W Pos 74% vs 50%
Options & Structure Winner ATRC
UNCLASSIFIED (74th %ile IV) vs UNCLASSIFIED (N/A IV)
ATRC NASDAQ
AtriCure, Inc.
Surgical & Medical Instruments & Apparatus
$55.39
+2.37% 1D
Market Cap $2.8B
1M Return -6.59%
1Y Return +62.05%
Forward P/E 122.1x
Unified AI Score
53.7 / 100 HOLD
Tech 42.0 Fund 47.0 Flow 50.0 Mom 50.0
AXNX US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap N/A
1M Return -26.54%
1Y Return +16.92%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ATRC +62.05% AXNX +16.92% Spread: +19.52 pp (AXNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ATRC TTM Op. Margin: 2.9% AXNX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ATRC vs AXNX. Trailing 12-month operating profitability (ATRC 2.9% vs AXNX N/A) and valuation multiples (ATRC 122.1x vs AXNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ATRC (9) vs AXNX (0)
Institutional Metric ATRC AXNX Criterion Row Winner
Market Capitalization Scale $2.8B N/A Larger Scale ATRC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation 122.1x N/M Lower Multiple ATRC
Revenue Growth (YoY) Growth +15.0% N/A Higher Growth ATRC
Operating Margin (TTM) Profitability 2.9% N/A Higher Margin ATRC
Net Profit Margin Profitability 2.5% N/A Higher Margin ATRC
Return on Equity (ROE) Capital Efficiency 2.9% N/A Higher ROE ATRC
52-Week Range Position Momentum 74% ($25โ€“$66) 50% ($0โ€“$1) Stronger Trend ATRC
Beta / 30D Volatility Risk Regime 0.47ฮฒ ยท 49% Vol N/A Lower Realized Risk ATRC
Unified Institutional Score Composite Signal 53.7 / 100 (HOLD) 52.1 / 100 (HOLD) Higher Composite ATRC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ATRC vs AXNX Buy Guide
ATRC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 74th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live ATRC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AXNX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AXNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ATRC nor AXNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.